Full Text
Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

Abstract

Authors

S.R. Gandra G. Villa G. Fonarow M. Lothgren P. Lindgren R. Somaratne B. van Hout

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×